Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atropine sulphate ophthalmic - Sinphar Pharmaceutical

Next Previous
Drug Profile

Atropine sulphate ophthalmic - Sinphar Pharmaceutical

Alternative Names: "Apricot" atropine eye drops 0.125%; "Apricot" atropine eye drops 0.3%; Atropine Eye Drops 0.125% "SINPHAR"; Atropine Eye Drops 0.3% "SINPHAR"

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sinphar Pharmaceutical
  • Class Alcohols; Alkaloids; Antidotes; Azabicyclo compounds; Bridged bicyclo compounds; Cardiovascular therapies; Esters; Eye disorder therapies; Propanols; Small molecules; Toluenes; Tropanes
  • Mechanism of Action Cholinergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Eye disorders; Mydriasis

Most Recent Events

  • 19 Jul 2017 Chemical structure information added
  • 31 May 2004 Launched for Eye disorders (Cycloplegia) in Taiwan (Ophthalmic) after May 2004 (Sinphar Pharmaceutical website, July 2017)
  • 31 May 2004 Launched for Mydriasis in Taiwan (Ophthalmic) after May 2004 (Sinphar Pharmaceutical website, July 2017)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top